Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of Atractylodes lancea

BACKGROUND AND AIM: Atractylodes lancea (AL) has been demonstrated in a series of studies to be a potential candidate for the treatment of cholangiocarcinoma. The aim of the current study was to evaluate the safety and pharmacokinetics of the capsule formulation of the standardized AL extract in hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Na-Bangchang, Kesara, Kulma, Inthuorn, Plengsuriyakarn, Tullayakorn, Tharavanij, Thipaporn, Kotawng, Kanawut, Chemung, Anurak, Muhamad, Nadda, Karbwang, Juntra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240349/
https://www.ncbi.nlm.nih.gov/pubmed/34195029
http://dx.doi.org/10.1016/j.jtcme.2021.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240349/
https://www.ncbi.nlm.nih.gov/pubmed/34195029
http://dx.doi.org/10.1016/j.jtcme.2021.02.002

Ejemplares similares